You are here
Porcilis® Lawsonia lyophilisate and solvent for emulsion for injection for pigs
This product page provides information relating to Porcilis Lawsonia, for intramuscular use. For intradermal administration please see the Porcilis Lawsonia ID product page.
Porcine proliferative enteritis is a common diarrhoeal disease of growing-finishing and young breeding pigs characterised by hyperplasia and inflammation of the ileum and small intestine.
Presentation
Lyophilisate: white/nearly white pellet/powder.
Solvent: homogenous white to nearly white emulsion after shaking.
Active ingredients
Each 2 ml dose contains:
Inactivated Lawsonia intracellularis strain SPAH-08 ≥ 5323 U1
1 Antigenic mass units as determined in the in vitro potency test (ELISA).
Target species
Pigs
Indications for use
For the active immunisation of pigs from 3 weeks of age to reduce diarrhoea, loss of daily weight gain, intestinal lesions, bacterial shedding and mortality caused by Lawsonia intracellularis infection.
Onset of immunity: 4 weeks after vaccination
Duration of immunity: 21 weeks after vaccination
Withdrawal period
Meat: zero days
Packaging
Lyophilisate: Hydrolytic glass Type I vial of 50 doses or 100 doses closed with halogenobutyl rubber stoppers and sealed with aluminium caps.
Solvent: PET (polyethylene terephthalate) vials of 100 ml (50 doses) or 200 ml (100 doses), closed with nitryl rubber stoppers and sealed with aluminium caps.
Cardboard box with 1 x 50 doses of vaccine and cardboard box with 1 x 100 ml solvent.
Cardboard box with 1 x 100 doses of vaccine and cardboard box with 1 x 200 ml solvent.
Legal category
POM-V
Further information is available from the SPC, datasheet or package leaflet.
Advice should be sought from the medicine prescriber.
Prescription decisions are for the person issuing the prescription alone.
Use Medicines Responsibly.
Product images are representations of packaging and may not accurately reflect the current packaging available in the GB marketplace.
Date of preparation: May 2025